Phillip Frost Net Worth is
Phillip Frost Bio/Wiki 2018
Phillip Frost Net Worth $3.7 Billion
In 1972, together with Michael Jaharis, Phillip Frost purchased the Key Pharmaceuticals Inc. The business was later acquired by Schering-Plough for $600 million. Frost received $100 for the sale. In 1987, Frost served as the Chief Executive Officer and Chairman of the Board of Managers at IVAX Corporation. In 2006, the business was acquired by an Israel-based pharmaceutical company Teva for $7.4 billion. He then served as the Vice Chairman of Teva in January 2006. In 2010, Frost became the Chairman of the Board of Managers and in May 2012, he was reelected to the place. Frost invested $24 million in Protalix Bio-Therapeutics making him the largest investor to the said business which develop the treatment for Gaucher Disease.